chr4-148436862-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000901.5(NR3C2):​c.-2C>G variant causes a splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.497 in 1,600,986 control chromosomes in the GnomAD database, including 204,490 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.44 ( 16724 hom., cov: 32)
Exomes 𝑓: 0.50 ( 187766 hom. )

Consequence

NR3C2
NM_000901.5 splice_region

Scores

2
Splicing: ADA: 0.00003813
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.27

Publications

96 publications found
Variant links:
Genes affected
NR3C2 (HGNC:7979): (nuclear receptor subfamily 3 group C member 2) This gene encodes the mineralocorticoid receptor, which mediates aldosterone actions on salt and water balance within restricted target cells. The protein functions as a ligand-dependent transcription factor that binds to mineralocorticoid response elements in order to transactivate target genes. Mutations in this gene cause autosomal dominant pseudohypoaldosteronism type I, a disorder characterized by urinary salt wasting. Defects in this gene are also associated with early onset hypertension with severe exacerbation in pregnancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
NR3C2 Gene-Disease associations (from GenCC):
  • autosomal dominant pseudohypoaldosteronism type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pseudohyperaldosteronism type 2
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 4-148436862-G-C is Benign according to our data. Variant chr4-148436862-G-C is described in ClinVar as Benign. ClinVar VariationId is 256827.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000901.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR3C2
NM_000901.5
MANE Select
c.-2C>G
splice_region
Exon 2 of 9NP_000892.2
NR3C2
NM_000901.5
MANE Select
c.-2C>G
5_prime_UTR
Exon 2 of 9NP_000892.2
NR3C2
NM_001437657.1
c.-2C>G
splice_region
Exon 2 of 9NP_001424586.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR3C2
ENST00000358102.8
TSL:1 MANE Select
c.-2C>G
splice_region
Exon 2 of 9ENSP00000350815.3
NR3C2
ENST00000512865.5
TSL:1
c.-2C>G
splice_region
Exon 2 of 8ENSP00000423510.1
NR3C2
ENST00000358102.8
TSL:1 MANE Select
c.-2C>G
5_prime_UTR
Exon 2 of 9ENSP00000350815.3

Frequencies

GnomAD3 genomes
AF:
0.444
AC:
67407
AN:
151864
Hom.:
16714
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.233
Gnomad AMI
AF:
0.344
Gnomad AMR
AF:
0.527
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.764
Gnomad SAS
AF:
0.648
Gnomad FIN
AF:
0.679
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.483
Gnomad OTH
AF:
0.424
GnomAD2 exomes
AF:
0.532
AC:
127947
AN:
240662
AF XY:
0.536
show subpopulations
Gnomad AFR exome
AF:
0.229
Gnomad AMR exome
AF:
0.568
Gnomad ASJ exome
AF:
0.419
Gnomad EAS exome
AF:
0.769
Gnomad FIN exome
AF:
0.676
Gnomad NFE exome
AF:
0.489
Gnomad OTH exome
AF:
0.497
GnomAD4 exome
AF:
0.503
AC:
728854
AN:
1449004
Hom.:
187766
Cov.:
32
AF XY:
0.506
AC XY:
364917
AN XY:
721122
show subpopulations
African (AFR)
AF:
0.226
AC:
7527
AN:
33250
American (AMR)
AF:
0.563
AC:
24810
AN:
44090
Ashkenazi Jewish (ASJ)
AF:
0.418
AC:
10875
AN:
26024
East Asian (EAS)
AF:
0.755
AC:
29934
AN:
39634
South Asian (SAS)
AF:
0.614
AC:
52771
AN:
85924
European-Finnish (FIN)
AF:
0.668
AC:
31412
AN:
47008
Middle Eastern (MID)
AF:
0.384
AC:
2204
AN:
5738
European-Non Finnish (NFE)
AF:
0.488
AC:
539869
AN:
1107268
Other (OTH)
AF:
0.490
AC:
29452
AN:
60068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
17752
35504
53255
71007
88759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15960
31920
47880
63840
79800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.444
AC:
67432
AN:
151982
Hom.:
16724
Cov.:
32
AF XY:
0.461
AC XY:
34210
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.233
AC:
9638
AN:
41416
American (AMR)
AF:
0.527
AC:
8053
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1390
AN:
3470
East Asian (EAS)
AF:
0.764
AC:
3953
AN:
5172
South Asian (SAS)
AF:
0.649
AC:
3120
AN:
4808
European-Finnish (FIN)
AF:
0.679
AC:
7170
AN:
10554
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.483
AC:
32799
AN:
67962
Other (OTH)
AF:
0.425
AC:
899
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1785
3569
5354
7138
8923
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.484
Hom.:
12187
Bravo
AF:
0.418
Asia WGS
AF:
0.676
AC:
2350
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 17, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This is a RefSeq error. The reference base (c.-2C) is the minor allele. This all ele (C) has been identified in 48.2% (28400/58962) of European chromosomes by th e Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs20 70951) and thus meets criteria to be classified as benign.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Autosomal dominant pseudohypoaldosteronism type 1 Benign:2
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28249922, 20855654, 20884124, 23315997, 12483305)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
10
DANN
Benign
0.58
PhyloP100
1.3
PromoterAI
-0.0022
Neutral
Mutation Taster
=288/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000038
dbscSNV1_RF
Benign
0.086
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070951; hg19: chr4-149358014; API